Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
KUAISHOU-W
01024
5
JD HEALTH
06618
| (FY)Mar 31, 2025 | (FY)Mar 31, 2024 | (FY)Mar 31, 2023 | (FY)Mar 31, 2022 | (FY)Mar 31, 2021 | |
|---|---|---|---|---|---|
| Operating cash flow (Indirect Method) | |||||
| Cash from operating activities | 610.94%654M | -500.00%-128M | 145.07%32M | 87.38%-71M | -562.42M |
| Net profit before non-cash adjustment | -261.99%-2.51B | -686.36%-692M | 54.64%-88M | 67.07%-194M | ---589.12M |
| Total adjustment of non-cash items | 199.04%3.43B | 640.65%1.15B | -16.22%155M | -17.55%185M | --224.38M |
| -Depreciation and amortization | 18.75%874M | 65.39%736M | 59.50%445M | 93.61%279M | --144.1M |
| -Reversal of impairment losses recognized in profit and loss | 537.17%2.43B | 9,450.00%382M | -92.45%4M | -61.24%53M | --136.75M |
| -Share of associates | ---70M | --0 | ---- | ---- | ---- |
| -Disposal profit | 780.95%143M | 92.81%-21M | -14,700.00%-292M | 94.93%2M | --1.03M |
| -Net exchange gains and losses | ---- | ---- | ---- | -55.95%3M | --6.81M |
| -Other non-cash items | 1.96%52M | 2,650.00%51M | 98.68%-2M | -136.37%-152M | ---64.31M |
| Changes in working capital | 53.07%-275M | -1,483.78%-586M | 44.78%-37M | 66.11%-67M | ---197.68M |
| -Change in receivables | -500.00%-76M | 115.97%19M | 57.65%-119M | -24.24%-281M | ---226.17M |
| -Change in payables | -193.85%-305M | 755.26%325M | -68.85%38M | 196.10%122M | --41.2M |
| -Provision for loans, leases and other losses | 320.00%21M | -37.50%5M | --8M | --0 | --0 |
| -Changes in other current assets | 95.47%-36M | -2,509.09%-795M | 135.71%33M | 219.58%14M | ---11.71M |
| -Changes in other current liabilities | 186.43%121M | -4,766.67%-140M | -96.15%3M | 7,892.21%78M | ---1M |
| Dividends paid (cash flow from operating activities) | |||||
| Dividends received (cash flow from operating activities) | |||||
| Interest paid (cash flow from operating activities) | 0.00%-27M | -2,600.00%-27M | 80.00%-1M | -15.87%-5M | -4.32M |
| Interest received (cash flow from operating activities) | 2M | 0 | 0 | 0 | 90K |
| Tax refund paid | 77.78%-10M | 16.67%-45M | -80.00%-54M | -315.11%-30M | -7.23M |
| Other operating cash inflow (outflow) | -33.33%2M | -96.81%3M | -27.69%94M | 184.20%130M | 45.74M |
| Operating cash flow | 415.23%621M | -377.46%-197M | 195.83%71M | 104.54%24M | ---528.13M |
| Investing cash flow | |||||
| Net PPE purchase and sale | -8.41%-116M | -55.07%-107M | 0.00%-69M | -4.02%-69M | ---66.34M |
| Net intangibles purchase and sale | -6.50%-869M | 3.43%-816M | -112.85%-845M | 19.81%-397M | ---495.07M |
| Net business purchase and sale | 104.93%96M | -526.97%-1.95B | 260.00%456M | -2,430.18%-285M | ---11.26M |
| Net investment product transactions | 0.00%-6M | -500.00%-6M | 87.50%-1M | ---8M | --0 |
| Net changes in other investments | 119.48%15M | -220.83%-77M | -141.38%-24M | 54,105.61%58M | --107K |
| Investing cash flow | 70.20%-880M | -511.39%-2.95B | 31.10%-483M | -22.43%-701M | ---572.57M |
| Financing cash flow | |||||
| Net issuance payments of debt | -112.25%-300M | 7,094.29%2.45B | 93.65%-35M | -168.88%-551M | --800M |
| Net common stock issuance | 107.52%78M | -1,239.56%-1.04B | -97.91%91M | 334.68%4.35B | --1B |
| Net other fund-raising expenses | 150.00%1M | -104.08%-2M | -40.24%49M | 38,947.62%82M | --210K |
| Financing cash flow | -115.68%-221M | 1,241.90%1.41B | -97.29%105M | 115.41%3.88B | --1.8B |
| Net cash flow | |||||
| Beginning cash position | -33.30%3.49B | -5.53%5.23B | 136.93%5.54B | 50.56%2.34B | --1.55B |
| Current changes in cash | 72.43%-480M | -467.10%-1.74B | -109.59%-307M | 357.57%3.2B | --699.57M |
| Effect of exchange rate changes | ---- | ---- | ---- | --0 | ---1.49M |
| Cash adjustments other than cash changes | 0.00%-1M | -200.00%-1M | 200.00%1M | -101.14%-1M | --87.37M |
| End cash Position | -13.79%3.01B | -33.30%3.49B | -5.53%5.23B | 136.86%5.54B | --2.34B |
| Free cash flow | 67.50%-364M | -32.86%-1.12B | -89.44%-843M | 59.16%-445M | ---1.09B |
| Currency Unit | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |